156 related articles for article (PubMed ID: 31372987)
1. Cutaneous intravascular NK/T-cell lymphoma.
Wang J; Yang X; Song Z; You Y
Australas J Dermatol; 2020 Feb; 61(1):61-63. PubMed ID: 31372987
[No Abstract] [Full Text] [Related]
2. Primary Cutaneous Gamma-Delta T-cell Lymphoma: Not an Aggressive Disease in All Cases.
Khallaayoune M; Grange F; Condamina M; Szablewski V; Guillot B; Dereure O
Acta Derm Venereol; 2020 Jan; 100(1):adv00035. PubMed ID: 31612963
[No Abstract] [Full Text] [Related]
3. Targeting Tumor-Infiltrating B Cells in Cutaneous T-Cell Lymphoma.
Theurich S; Schlaak M; Steguweit H; Heukamp LC; Wennhold K; Kurschat P; Rabenhorst A; Hartmann K; Schlösser H; Shimabukuro-Vornhagen A; Holtick U; Hallek M; Stadler R; von Bergwelt-Baildon M
J Clin Oncol; 2016 Apr; 34(12):e110-6. PubMed ID: 25348001
[No Abstract] [Full Text] [Related]
4. Proceedings of the Second International Symposium on Cutaneous T-cell Lymphoma. Chicago, Illinois, Oct. 13-17, 1993.
Herrmann JJ; Kuzel TM; Rosen ST; Roenigk HH
J Am Acad Dermatol; 1994 Nov; 31(5 Pt 1):819-22. PubMed ID: 7523465
[No Abstract] [Full Text] [Related]
5. Aggressive CD4-CD8-CD45RA+CCR10- Primary Cutaneous Peripheral T-cell Lymphoma, Not Otherwise Specified: A Case Report.
Ikumi N; Fujita H; Terui T; Takahashi H; Miura K; Hatta Y; Takei M
Acta Derm Venereol; 2019 Nov; 99(12):1176-1177. PubMed ID: 31502655
[No Abstract] [Full Text] [Related]
6. Cytotoxic/suppressor (CD8+, CD4-) cutaneous T-cell lymphoma with aggressive course.
Urrutia S; Piris MA; Orradre JL; Martinez B; Cruz MA; Garcia-Almagro D
Am J Dermatopathol; 1990 Dec; 12(6):603-6. PubMed ID: 2125178
[TBL] [Abstract][Full Text] [Related]
7. CD4/CD8 double-negative T-cell lymphoma: a variant of primary cutaneous CD8+ aggressive epidermotropic cytotoxic T-cell lymphoma?
Miyauchi T; Abe R; Morita Y; Adachi M; Shiba K; Hamade Y; Saito N; Nishimura M; Ibata M; Okada K; Shigematsu A; Endo T; Kawai K; Teshima T; Shimizu H
Acta Derm Venereol; 2015 Nov; 95(8):1024-5. PubMed ID: 25792011
[No Abstract] [Full Text] [Related]
8. [Nasal-type NK/T-cell lymphoma primary in skin].
Gao LX; Leng YM; Ding HY
Zhonghua Bing Li Xue Za Zhi; 2005 Oct; 34(10):689-90. PubMed ID: 16536290
[No Abstract] [Full Text] [Related]
9. Extracorporeal photochemotherapy in the early treatment of cutaneous T-cell lymphoma.
Fimiani M; Rubegni P; D'Ascenzo G; Andreassi L
J Am Acad Dermatol; 1994 Nov; 31(5 Pt 1):828-30. PubMed ID: 7929941
[No Abstract] [Full Text] [Related]
10. Cutaneous intravascular natural killer-cell lymphoma: a rare case and review of the literature.
Liao JB; Hsieh PP; Hwang YC; Lin SL; Wu CS
Acta Derm Venereol; 2011 Jun; 91(4):472-3. PubMed ID: 21394417
[No Abstract] [Full Text] [Related]
11. Fatal Case of Primary Cutaneous Aggressive T-Cell Lymphoma Switching From a CD4+ to a CD8+ Phenotype: Progressive Disease With Bexarotene and Romidepsin Treatment.
Johnson WT; Leeman-Neill RJ; Patel P; Ho J; Grandinetti LM; Jedrych J; Craig FE
Am J Dermatopathol; 2016 Nov; 38(11):832-837. PubMed ID: 27322928
[TBL] [Abstract][Full Text] [Related]
12. Subcutaneous panniculitis-like T-cell lymphoma αβ: complete sustained remission with corticosteroids and methotrexate.
Briki H; Bouaziz JD; Molinier-Frenkel V; Delfau-Larue MH; Ortonne N; Bagot M
Br J Dermatol; 2010 Nov; 163(5):1136-8. PubMed ID: 20649797
[No Abstract] [Full Text] [Related]
13. Cutaneous T-cell lymphoma presenting as facial swelling: report of a case and review of the literature.
Thomas DW; Lewis MA; Cowpe JG
Int J Oral Maxillofac Surg; 1994 Dec; 23(6 Pt 1):356-8. PubMed ID: 7699274
[TBL] [Abstract][Full Text] [Related]
14. Treatment of cutaneous T-cell lymphoma with alitretinoin gel.
Bassiri-Tehrani S; BA BA; Cohen DE
Int J Dermatol; 2002 Feb; 41(2):104-6. PubMed ID: 11982647
[No Abstract] [Full Text] [Related]
15. Primary cutaneous CD4/CD8-/- TCRαβ T-cell lymphoma.
Fujimoto N; Kito K; Yoshida T; Tanaka T
Acta Derm Venereol; 2015 Jan; 95(1):106-7. PubMed ID: 24890876
[No Abstract] [Full Text] [Related]
16. Orbital and Intraocular Lymphoma in Contralateral Eyes: A Case of Cutaneous Aggressive CD-8+ T-Cell Lymphoma.
Komanski C; Weinlander K; Yeatts P
Ophthalmology; 2017 May; 124(5):687. PubMed ID: 28433127
[No Abstract] [Full Text] [Related]
17. [Management of cutaneous lymphoma ].
Beylot-Barry M; Battistella M
Ann Dermatol Venereol; 2011 May; 138(5 Suppl 2):H13-8. PubMed ID: 21703465
[No Abstract] [Full Text] [Related]
18. Leukaemic cutaneous T-cell lymphoma-manifesting papuloerythroderma with CD3(-) CD4(+) phenotype.
Shimauchi T; Sugita K; Nakamura M; Tokura Y
Acta Derm Venereol; 2010; 90(1):68-72. PubMed ID: 20107729
[TBL] [Abstract][Full Text] [Related]
19. Long-term bexarotene monotherapy in large cell CD30+ pleomorphic T-cell lymphoma.
Aldaoud A
Dermatol Clin; 2008 Jan; 26 Suppl 1():15-7. PubMed ID: 18405181
[No Abstract] [Full Text] [Related]
20. 2-Chlorodeoxyadenosine: an active agent in the treatment of cutaneous T-cell lymphoma.
Saven A; Carrera CJ; Carson DA; Beutler E; Piro LD
Blood; 1992 Aug; 80(3):587-92. PubMed ID: 1353380
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
